Compare CVS Health Corp (CVS) vs Tidewater Inc (TDW) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
CVS Health Corp vs Tidewater Inc — how do they compare? CVS Health Corp trades at $93.7 (market cap $122.36B), while Tidewater Inc trades at $91.5 (market cap $4.46B). The key difference: CVS Health Corp is far larger — about 27.4× Tidewater Inc's market cap, and CVS Health Corp pays a 2.78% dividend while Tidewater Inc pays none. Which is the better fit depends on your goals.
| CVS | TDW | |
|---|---|---|
Market Cap | $122.36B | $4.46B |
Sector | Health | Utilities |
52-Week High | $110.60 | $91.20 |
52-Week Low | $65.51 | $47.29 |
Enterprise Value | $184.71B | $4.50B |
Dividend Yield | 2.78% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CVS Health trades at $95.70, down 0.54% on the day, with a bearish technical signal and key support at $95. The company reported strong Q2 2026 earnings, beating estimates with EPS of $2.58 versus $1.87 expected, and raised its full-year guidance. Revenue growth remains robust, reaching $402.07 billion in 2025, though net income margin compressed to 1.18%. Analyst sentiment is overwhelmingly positive with a consensus price target of $115.00.
The outlook for CVS is cautiously optimistic, driven by operational improvements in its Aetna segment and raised cash flow guidance. Investment opportunities include potential upside to the consensus target, but risks involve margin pressures, regulatory changes impacting pharmacy benefits in 2027, and high debt levels. The stock's current valuation at a P/E of 25.25 may limit near-term gains if earnings growth slows.
Tidewater (TDW) trades at $82.84, up 1.56% today, with a bullish technical signal from moving averages and strong support at $81. The company reported Q2 2026 EPS of $0.43, beating estimates, but has missed expectations in recent quarters. Revenue for 2025 was $1.35B with a net income margin of 18.34%, though 2026 projections show a decline to $1.3B and lower margins. Analyst consensus is mixed with 26.92% buy ratings, while institutional holdings saw increases from First Trust Advisors and Bank of New York Mellon in 2026.
Outlook: TDW benefits from operational strength and bullish technicals, but earnings misses and margin compression pose risks. Investors should weigh solid cash flow against competitive and macroeconomic headwinds in the oil and gas sector.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About CVS Health Corp
Following its acquisition of Aetna in late 2018, CVS Health now provides an even more integrated healthcare-services offering for its members. Legacy CVS combined both the largest pharmacy benefit manager, processing over 2 billion adjusted claims annually, and a sizable pharmacy operation, including nearly 10,000 retail pharmacy locations primarily in the U.S. Adding a managed-care organization with 24 million medical members gives the company a strong position in the insurance industry and should help CVS better control overall healthcare costs for its clients.
Read more on CVS →About Tidewater Inc
Tidewater is the leading global provider of offshore support vessels (OSVs) to the energy industry. With the world's largest fleet of platform supply vessels (PSVs) and anchor handling tugs (AHTS), it provides critical logistics and marine support for offshore oil, gas, and renewable energy projects. Following a period of massive strategic consolidation, Tidewater is now focused on maximizing day rates and free cash flow in a supply-constrained market, positioning itself as a primary beneficiary of the multi-year offshore upcycle.
Read more on TDW →
